ANALYSIS China's public markets are absorbing AI and robotics companies at a pace that outstrips 2025, yet the first real earnings from humanoid-robot makers and a deflating fast-fashion listing expose a widening gap between investor appetite and commercial proof.
Why it matters
Hong Kong and Shanghai have raised more than $54 billion in IPOs and secondary listings so far in 2026, already surpassing the full-year 2025 total of more than $46 billion, according to LSEG data cited by the Associated Press7,8. That puts the two exchanges at roughly 21% of global IPO proceeds, behind Nasdaq's 55% share. The boom is concentrated in AI-adjacent hardware: memory chips, humanoid robots, and the supply chains around them. "The current IPO boom is powered by investor appetite for AI and robotics," said Ruiying Zhao, a senior research analyst at S&P Global Market Intelligence12. The question is whether public-market discipline can keep pace with the capital flowing in.
The big picture
Three listings frame the spectrum. CXMT, China's largest memory chipmaker, raised more than $8.6 billion on Shanghai's STAR market in July; its shares jumped 466% on the first day of trading11. Unitree Robotics, a humanoid-robot maker, debuted in Shanghai in August with a 460% first-day surge that valued the company at $50 billion9. And Shein, the fast-fashion platform, raised $1.7 billion in Hong Kong at a valuation of about $26 billion, far below its peak of roughly $100 billion in 20221,4. Shein's shares dropped as much as 10% intraday before closing down just 0.1% from the IPO price at HK$48.50.
Perris Lee, head of APAC equity capital markets for ION Analytics, said CXMT's IPO "placed China in a strategically significant position in tech manufacturing related to AI" and called it "a testament to China's tech self-sufficiency ambitions". ANALYSIS The contrast across these three debuts is stark: investors paid enormous premiums for companies tied to AI silicon and robotics while marking down an unprofitable consumer-internet name that once commanded a far higher private valuation.
Between the lines
UBTech Robotics, already public in Hong Kong, offers the closest look at whether the robotics hype translates into revenue. In the first half of 2026, UBTech's total revenue rose 104.2% year-on-year to RMB 1.27 billion ($188.5 million)2,5. Revenue from full-size humanoid robots surged 1,445% to RMB 590.3 million from RMB 38.2 million a year earlier, making it 46.5% of group revenue10. The company sold 921 full-size humanoid robots, up 1,946.7%. Gross margin rose 9.7 percentage points to 44.7%, and UBTech attributed the improvement mainly to the higher contribution from full-size humanoid products, which carry higher gross margins.
Yet UBTech remained loss-making. Its net loss narrowed 23.0% to RMB 338.8 million ($50.3 million), while adjusted EBITDA losses shrank by 45.9%. R&D expenses rose 38.9% to RMB 303.1 million. ANALYSIS The company is spending nearly as much on R&D as it loses, a profile that rewards growth narratives but punishes any deceleration.
The sector's trading behavior reinforces that fragility. Unitree's blockbuster debut drained capital from established names: UBTech shed more than 10% intraday on the day of Unitree's listing. Days later, Unitree itself collapsed by over 10%, erasing 20 billion yuan in market value and dragging UBTech and the broader Chinese humanoid-robotics complex into a sell-off. ◆ In a market where a rival's first-day pop can siphon capital and its subsequent stumble can crater the entire sector, individual fundamentals are periodically overwhelmed by rotation trades.
UBTech is also broadening its product line. Its Uworld U1 companion robot, billed as the first mass-produced humanoid built for emotional connection, carries a price range of 119,800 to 990,000 yuan and has drawn more than 13,000 pre-orders6. Independent reports, however, suggest actual response times stretch to several seconds despite a claimed lip-sync latency under 20 milliseconds, and critics have described the emotional interaction as unnatural.
What's next
Total humanoid-robot sales across all UBTech categories reached 16,123 units in the first half, up 268.3%. The $54 billion raised so far in 2026 across Hong Kong and Shanghai already exceeds the more than $46 billion raised in all of 2025. ANALYSIS But the pattern within that total is uneven: chipmakers and robotics names command enormous first-day premiums, while Shein, once valued at roughly $100 billion privately, arrives at $26 billion and trades flat. UBTech's interim results show that triple-digit revenue growth and narrowing losses can coexist with violent share-price swings driven by sector-level speculation rather than company-level performance. Whether that trajectory holds will determine if the robotics premium survives its first full earnings cycle as a public-market trade.